UPDATE: Momenta Pharma (MNTA) 'Compelling'; UBS Raises to Buy
Tweet Send to a Friend
(Updated - June 6, 2013 8:43 AM EDT)
UBS upgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Neutral to Buy with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS upgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Neutral to Buy with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
